| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:731769 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FMO4 mRNA | CTD | PMID:18765683 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FMO4 mRNA | CTD | PMID:21215274 PMID:21724226 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:731769 | 6480464 | Tetrachlorodibenzodioxin affects the expression of FMO4 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FMO4 mRNA | CTD | PMID:21215274 |
| aflatoxin B1 | decreases expression | ISO | RGD:731768 | 6480464 | Aflatoxin B1 results in decreased expression of FMO4 mRNA | CTD | PMID:22100608 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of FMO4 mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | increases expression | ISO | RGD:731769 | 6480464 | Benzo(a)pyrene results in increased expression of FMO4 mRNA | CTD | PMID:19770486 |
| calcitriol | multiple interactions | ISO | RGD:731768 | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of FMO4 mRNA | CTD | PMID:21592394 |
| calcitriol | increases expression | ISO | RGD:731768 | 6480464 | Calcitriol results in increased expression of FMO4 mRNA | CTD | PMID:21592394 |
| chloroprene | increases expression | ISO | RGD:731769 | 6480464 | Chloroprene results in increased expression of FMO4 mRNA | CTD | PMID:23125180 |
| cholic acid | increases expression | ISO | RGD:731769 | 6480464 | Cholic Acid results in increased expression of FMO4 mRNA | CTD | PMID:17521389 |
| copper atom | decreases expression | EXP | | 6480464 | Copper results in decreased expression of FMO4 mRNA | CTD | PMID:22465980 |
| copper(0) | decreases expression | EXP | | 6480464 | Copper results in decreased expression of FMO4 mRNA | CTD | PMID:22465980 |
| cyclosporin A | decreases expression | ISO | RGD:731768 | 6480464 | Cyclosporine results in decreased expression of FMO4 mRNA | CTD | PMID:20106945 |
| cytarabine | decreases expression | ISO | RGD:731768 | 6480464 | Cytarabine results in decreased expression of FMO4 mRNA | CTD | PMID:21198554 |
| monocrotaline | multiple interactions | ISO | RGD:731769 | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of FMO4 mRNA | CTD | PMID:21224054 |
| paracetamol | decreases expression | ISO | RGD:731768 | 6480464 | Acetaminophen results in decreased expression of FMO4 mRNA | CTD | PMID:21420995 |
| phenobarbital | multiple interactions | ISO | RGD:731769 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of FMO4 mRNA] | CTD | PMID:19482888 |
| phenobarbital | increases expression | ISO | RGD:731769 | 6480464 | Phenobarbital results in increased expression of FMO4 mRNA | CTD | PMID:19270015 PMID:19482888 |
| phenobarbital | increases expression | ISO | RGD:731769 | 6480464 | Phenobarbital results in increased expression of FMO4 mRNA | CTD | PMID:19482888 PMID:19270015 |
| phenytoin | multiple interactions | ISO | RGD:731769 | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of FMO4 mRNA | CTD | PMID:21224054 |
| pirinixic acid | increases expression | ISO | RGD:731769 | 6480464 | pirinixic acid results in increased expression of FMO4 mRNA | CTD | PMID:18301758 |
| rifampicin | multiple interactions | ISO | RGD:731769 | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of FMO4 mRNA | CTD | PMID:21224054 |
| testosterone | increases expression | ISO | RGD:731768 | 6480464 | Testosterone results in increased expression of FMO4 mRNA | CTD | PMID:21592394 |
| testosterone | multiple interactions | ISO | RGD:731768 | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of FMO4 mRNA | CTD | PMID:21592394 |
| valproic acid | affects expression | ISO | RGD:731769 | 6480464 | Valproic Acid affects the expression of FMO4 mRNA | CTD | PMID:17963808 |
| zinc atom | decreases expression | ISO | RGD:731768 | 6480464 | Zinc deficiency results in decreased expression of FMO4 mRNA | CTD | PMID:12888634 |
| zinc(0) | decreases expression | ISO | RGD:731768 | 6480464 | Zinc deficiency results in decreased expression of FMO4 mRNA | CTD | PMID:12888634 |